Product
Sinovac PCV13
1 clinical trial
1 indication
Indication
Pneumococcal Infectious DiseaseClinical trial
A Randomized, Double Blinded, Positive Controlled Phase Ⅰb Clinical Trial in Participants Aged 2 Months (42-89 Days) and 2 to 5 Years to Evaluate the Safety and Immunogenicity of 13-valent Pneumococcal Polysaccharide Conjugate VaccineStatus: Recruiting, Estimated PCD: 2024-09-02